The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation
Open accessAbstract
Promyelocytic leukemia (PML) is the organizer of nuclear matrix domains, PML nuclear bodies (NBs), with a proposed role in apoptosis control. In acute promyelocytic leukemia, PML/retinoic acid receptor (RAR) α expression disrupts NBs, but therapies such as retinoic acid or arsenic trioxide (As2O3) restore them. PML is conjugated by the ubiquitin-related peptide SUMO-1, a process enhanced by As2O3 and proposed to target PML to the nuclear matrix. We demonstrate that As2O3 triggers the proteasome-dependent degradation of PML and PML/RARα and that this process requires a specific sumolation site in PML, K160. PML sumolation is dispensable for its As2O3-induced matrix targeting and formation of primary nuclear aggregates, but is required for the formation of secondary shell-like NBs. Interestingly, only these mature NBs harbor 11S proteasome components, which are further recruited upon As2O3 exposure. Proteasome recruitment by sumolated PML only likely accounts for the failure of PML-K160R to be degraded. Therefore, studying the basis of As2O3-induced PML/RARα degradation we show that PML sumolation directly or indirectly promotes its catabolism, suggesting that mature NBs could be sites of intranuclear proteolysis and opening new insights into NB alterations found in viral infections or transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Self-citationMahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 1×
“In that respect, the function of several proteins involved in degradation complexes is enhanced when they become modified by SUMO or Nedd8 (42).”
BackgroundSUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Self-citationIshov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
Self-citationPml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
Self-citationPML is induced by oncogenic ras and promotes premature senescence
Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., & Lowe, S. W. (2000) · Genes & Development · doi:10.1101/gad.14.16.2015 · Cited by 536
Ubiquitination: RING for destruction?
Freemont, P. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00287-6 · Cited by 522
Self-citationRole of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Self-citationZhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Self-citationp300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
Self-citationvom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., & Losson, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00339.x · Cited by 399
Henderson, B. R., & Eleftheriou, A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4825 · Cited by 387
PML induces a novel caspase-independent death process
Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.-C., & de Thé, H. (1998) · Nature Genetics · doi:10.1038/3068 · Cited by 374
Self-citationZhu, J., Gianni, M., Kopf, E., Honoré, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., & de Thé, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14807 · Cited by 372
Self-citationSequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML
Li, H., Leo, C., Zhu, J., Wu, X., O'Neil, J., Park, E.-J., & Chen, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1784-1796.2000 · Cited by 364
Self-citationShao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.124 · Cited by 344
Nuclear bodies: multifaceted subdomains of the interchromatin space
Matera, A. G. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01606-2 · Cited by 332
Chelbi-Alix, M. K., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202366 · Cited by 332
Self-citationDuprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., Thé, H. D., Hay, R. T., & Freemont, P. S. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.381 · Cited by 312
Self-citationIdentification of Three Major Sentrinization Sites in PML
Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26675 · Cited by 310
Müller, S., & Dejean, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5137-5143.1999 · Cited by 304
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
Torii, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6037 · Cited by 272
Stadler, M., Chelbi‐Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saı̈b, A., Quignon, F., Pelicano, L., Guillemin, M.-C., & Schindler, C. (1995) · PubMed · Cited by 266
Self-citationPandolfi, P. P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., Lo Coco, F., Rambaldi, A., & Grignani, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05185.x · Cited by 262
Self-citationA monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
Stuurman, N., Graaf, A. D., Floore, A., Josso, A., Humbel, B., Jong, L. D., & Driel, R. V. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.773 · Cited by 256
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Self-citationPromyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis
Zhong, S., Salomoni, P., Ronchetti, S., Guo, A., Ruggero, D., & Pandolfi, P. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.631 · Cited by 244
Self-citationLocalization of nascent RNA and CREB binding protein with the PML-containing nuclear body
LaMorte, V. J., Dyck, J. A., Ochs, R. L., & Evans, R. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4991 · Cited by 239
Intracellular Localization of Proteasomal Degradation of a Viral Antigen
Antón, L. C., Schubert, U., Bacík, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P. M., Realini, C., Rechsteiner, M. C., Bennink, J. R., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.113 · Cited by 215
Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins
Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3117 · Cited by 207
Doucas, V., Tini, M., Egan, D. A., & Evans, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2627 · Cited by 170
Nervi, C., Ferrara, F. F., Fanelli, M., Rippo, M. R., Tomassini, B., Ferrucci, P. F., Ruthardt, M., Gelmetti, V., Gambacorti-Passerini, C. B., Diverio, D., et al. (1998) · PubMed · doi:10.1182/blood.v92.7.2244 · Cited by 169
Negative Selection during the Peripheral Immune Response to Antigen
Anderton, S. M., Radu, C. G., Lowrey, P. A., Ward, E. S., & Wraith, D. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.1 · Cited by 164
Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
Rego, E. M., Wang, Z.-G., Peruzzi, D., He, L.-Z., Cordon-Cardo, C., & Pandolfi, P. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.521 · Cited by 161
Self-citationZhong, S., Delva, L., Rachez, C., Cenciarelli, C., Gandini, D., Zhang, H., Kalantry, S., Freedman, L. P., & Pandolfi, P. P. (1999) · Nature Genetics · doi:10.1038/15463 · Cited by 126
Self-citationRegulation of Pax3 transcriptional activity by SUMO-1-modified PML
Lehembre, F., Müller, S. P., Pandolfi, P. P., & Dejean, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204063 · Cited by 118
Self-citationFlenghi, L., Fagioli, M., Tomassoni, L., Pileri, S. A., Gambacorta, M., Pacini, R., Grignani, F., Casini, T., Ferrucci, P. F., Martelli, M., et al. (1995) · Blood · doi:10.1182/blood.v85.7.1871.bloodjournal8571871 · Cited by 102
A Critical Role for the Proteasome Activator PA28 in the Hsp90-dependent Protein Refolding
Minami, Y., Kawasaki, H., Minami, M., Tanahashi, N., Tanaka, K., & Yahara, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9055 · Cited by 88
Fabunmi, R. P., Wigley, W. C., Thomas, P., & Demartino, G. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.29 · Cited by 86
Lam, Y. W., AMMERLAAN, W. A. M., W.-S., O., Kroese, F. G. M., & Opstelten, D. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1384 · Cited by 15
Cited by
Phthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Hay, R. T. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.012 · Cited by 1,622
TRIM family proteins and their emerging roles in innate immunity
Ozato, K., Shin, D.-M., Chang, T.-H., & Morse, H. C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2413 · Cited by 1,120
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Metadata
- Authors
- Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., & de Thé, H.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-06-11
- Volume
- 193
- Issue
- 12
- Pages
- 1361-1372
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2107954651
- Cited by
- 488
- References
- 48
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.